Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lu Q Le

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
Cancer Discovery|October 24, 2018
Spatiotemporal Loss of <i>NF1</i> in Schwann Cell Lineage Leads to Different Types of Cutaneous Neurofibroma Susceptible to Modification by the Hippo PathwayZhiguo Chen, Juan Mo, Jean-Philippe Brosseau, et al.
Cancer Research|November 29, 2013
Preclinical therapeutic efficacy of a novel pharmacologic inducer of apoptosis in malignant peripheral nerve sheath tumorsVincent Chau, S Kyun Lim, Wei Mo, et al.
The Journal of Investigative Dermatology|June 18, 2023
Existing and Developing Preclinical Models for Neurofibromatosis Type 1-Related Cutaneous NeurofibromasVerena Staedtke, Piotr Topilko, Lu Q Le, et al.
Cell|February 26, 2013
CXCR4/CXCL12 mediate autocrine cell- cycle progression in NF1-associated malignant peripheral nerve sheath tumorsWei Mo, Jian Chen, Amish Patel, et al.
Science Advances|May 1, 2024
Effect of NFX-179 MEK inhibitor on cutaneous neurofibromas in persons with neurofibromatosis type 1Kavita Y Sarin, Mark Bradshaw, Chris O'Mara, et al.
Journal of the American Academy of Dermatology|October 8, 2025
Measurement of the severity related to cutaneous neurofibromas in neurofibromatosis type 1: Development and validation of the Nef-ASILaura Fertitta, Arnaud Jannic, Christina Bergqvist, et al.
Science Advances|June 20, 2025
TGFβ-dependent signaling drives tumor growth and aberrant extracellular matrix dynamics in NF1-associated plexiform neurofibromaMohannad Abu-Sultanah, Zhuan Zhou, Chunhui Jiang, et al.
American Journal of Medical Genetics. Part A|April 23, 2018
2016 Children's Tumor Foundation conference on neurofibromatosis type 1, neurofibromatosis type 2, and schwannomatosisMichael J Fisher, Allan J Belzberg, Peter de Blank, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Cancer Discovery|October 24, 2018
Spatiotemporal Loss of <i>NF1</i> in Schwann Cell Lineage Leads to Different Types of Cutaneous Neurofibroma Susceptible to Modification by the Hippo PathwayZhiguo Chen, Juan Mo, Jean-Philippe Brosseau, et al.
Cancer Research|November 29, 2013
Preclinical therapeutic efficacy of a novel pharmacologic inducer of apoptosis in malignant peripheral nerve sheath tumorsVincent Chau, S Kyun Lim, Wei Mo, et al.
The Journal of Investigative Dermatology|June 18, 2023
Existing and Developing Preclinical Models for Neurofibromatosis Type 1-Related Cutaneous NeurofibromasVerena Staedtke, Piotr Topilko, Lu Q Le, et al.
Cell|February 26, 2013
CXCR4/CXCL12 mediate autocrine cell- cycle progression in NF1-associated malignant peripheral nerve sheath tumorsWei Mo, Jian Chen, Amish Patel, et al.
Science Advances|May 1, 2024
Effect of NFX-179 MEK inhibitor on cutaneous neurofibromas in persons with neurofibromatosis type 1Kavita Y Sarin, Mark Bradshaw, Chris O'Mara, et al.
Journal of the American Academy of Dermatology|October 8, 2025
Measurement of the severity related to cutaneous neurofibromas in neurofibromatosis type 1: Development and validation of the Nef-ASILaura Fertitta, Arnaud Jannic, Christina Bergqvist, et al.
Science Advances|June 20, 2025
TGFβ-dependent signaling drives tumor growth and aberrant extracellular matrix dynamics in NF1-associated plexiform neurofibromaMohannad Abu-Sultanah, Zhuan Zhou, Chunhui Jiang, et al.
American Journal of Medical Genetics. Part A|April 23, 2018
2016 Children's Tumor Foundation conference on neurofibromatosis type 1, neurofibromatosis type 2, and schwannomatosisMichael J Fisher, Allan J Belzberg, Peter de Blank, et al.
Pageof 7